Page 60 - Chief Operating News Today

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Phase 2 dose expansion currently underway at the RP2CDs of...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will...

By Exec Edge Editorial Staff Thank you both for joining me today. Let’s start with a little about yourselves and your organizations. Can you tell our readers a little about Aeries and Alegeus? Ajay: Of course – my name is Ajay Khare and I’m the Chief Operating & Revenue Officer at Aeries Technology. I’ve been […]

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

The Society for Hospitality & Foodservice Management (SHFM) welcomes Ed Mugnani, COO of Krafted Kitchen Collection, to Board of Directors

As with Google Docs and similar cloud-based document editing platforms, users can assign others to specific comments or issues.

BX earnings call for the period ending December 31, 2023.

PORTLAND, Maine, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Northeast Bank (the "Bank") (NASDAQ:NBN), a Maine-based full-service bank, announced today it will release its fiscal 2024 second quarter earnings results on Tuesday,

ROSEMONT, Ill., Jan. 25, 2024 -- Wintrust Financial Corporation today announced that the Company’s Board of Directors approved a quarterly cash dividend of $0.45 per share of outstanding common...

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Phase 2 dose expansion currently underway at the RP2CDs of masofaniten 600 mg BID in combination with...